Reproductive Health & Justice FDA Adverse Event Data FOIA April 1, 2026 Rifan Muazin The submission of a Freedom of Information Act (FOIA) request on March 20, 2026, seeking comprehensive safety data on mifepristone, marks a significant development in the ongoing scrutiny of this…
Reproductive Health & Justice FDA Adverse Event Data FOIA March 25, 2026 Rifan Muazin Advocacy Group Demands FDA Transparency on Mifepristone Safety Data Amidst Ongoing Legal Battles A prominent reproductive rights advocacy organization has formally requested detailed safety data pertaining to mifepristone, a medication…
